Bardet Biedl Syndrome

Four Vision Research and Treatment Trends to Watch in 2018

With the December 2017 announcement that the world’s first ocular gene therapy had received approval by the U.S. Food and Drug Administration (FDA), there’s no doubt that 2017 was a landmark year…

First gene therapy for a blinding eye disease receives FDA approval

Today we are celebrating the FDA’s pathbreaking approval of Luxturna. We have been following the development of Luxturna closely. Today’s landmark FDA approval makes Luxturna the first gene therapy approved in the…

Survival of the Fittest: Sustaining Cells Through Transplantation

In many retinal diseases, vision loss occurs when cells that are crucial for vision are damaged or lost. This is the case, for example, in age-related macular degeneration (AMD), retinitis pigmentosa, choroideremia,…

Clinician-Scientist Emerging Leader Award: Dr. Brian Ballios

Dr. Brian Ballios has restored vision in mice, but he is not stopping there. He is on a mission to develop stem cell therapies for people living with blindness and has a…

Top 10 Science-y Summer Tips

So far this year, the pace of vision research has been sizzling! To celebrate the arrival of sizzling weather, we asked Fighting Blindness Canada (FBC) staff to share their favourite FBC science…

Let’s Talk Gene Therapy Research With Dr. Mary Sunderland & Dr. Chad Andrews (VIDEO)

On the first Tuesday of every month, Fighting Blindness Canada sends out eNews, our e-newsletter featuring the latest and most exciting research breakthroughs. Soon after each eNews, our very own Director of Research and…

Join the Fight!

Learn how your support is helping to bring a future without blindness into focus! Be the first to learn about the latest breakthroughs in vision research and events in your community by subscribing to our e-newsletter that lands in inboxes the beginning of each month.